Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer

dc.contributor.author	Mateu Sanz, Miguel
dc.contributor.author	Ginebra, María-Pau
dc.contributor.author	Tornín Cavielles, Juan
dc.contributor.author	Canal, Cristina
dc.date.accessioned	2023-03-15T10:34:26Z
dc.date.available	2023-03-15T10:34:26Z
dc.date.issued	2022
dc.identifier.citation	Free Radical Biology and Medicine, 189, p. 32-41 (2022); doi:10.1016/j.freeradbiomed.2022.07.007
dc.identifier.issn	0891-5849
dc.identifier.issn	1873-4596
dc.identifier.uri	http://hdl.handle.net/10651/67067
dc.description.sponsorship	European Research Council (ERC), H2020 [714793]; MINECO [PID2019-103892RB-I00]; Generalitat de Catalunya [2020 FI-B00999]; ICREA Academia Award for Excellence in Research - Generalitat de Catalunya
dc.format.extent	p. 32-41
dc.language.iso	eng
dc.relation.ispartof	Free Radical Biology and Medicine
dc.rights	© 2022 The authors. Published by Elsevier Inc.
dc.rights	CC Reconocimiento - No Comercial 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/
dc.source	WOS:000835271700003
dc.title	Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer
dc.type	journal article
dc.identifier.doi	10.1016/j.freeradbiomed.2022.07.007
dc.relation.projectID	info:eu‐repo/grantAgreement/EC/H2020/714793
dc.relation.projectID	MINECO/PID2019-103892RB-I00
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.freeradbiomed.2022.07.007
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Artículos [34686]
Biología Funcional [741]
Investigaciones y Documentos OpenAIRE [7639]
Publicaciones resultado de proyectos financiados con fondos públicos

Este ítem está sujeto a una licencia Creative Commons